The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease

Research on the neuroprotective effect of pituitary adenylate cyclase-activating polypeptide (PACAP) and its use as a therapeutic agent has grown over the past 30 years. Both in vitro and in vivo experiments have shown that PACAP exerts a strong neuroprotective effect in many central and peripheral...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Asma Cherait, William A. Banks, David Vaudry
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Subjects:	pituitary adenylate cyclase-activating polypeptide intranasal delivery route neuronal diseases neuroprotection apoptosis inflammation
Online Access:	https://www.mdpi.com/1999-4923/15/8/2032